NYU Clinical Cancer Center — New York, New York

NYU Clinical Cancer Center is a clinical research site located in New York, New York, United States 97219.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

NYU Clinical Cancer Center has participated in 36 clinical trials.

Therapeutic areas: Relapsed or Refractory Lymphoid Malignancies, Lymphoma, Multiple Myeloma.

Sponsors: OncoMed Pharmaceuticals, Inc., Bristol-Myers Squibb, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Clinical Cancer Center?

NYU Clinical Cancer Center has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Clinical Cancer Center conducted?

NYU Clinical Cancer Center has 36 clinical trials on record. Their work covers Relapsed or Refractory Lymphoid Malignancies, Lymphoma, Multiple Myeloma.

Is NYU Clinical Cancer Center accredited by Crixeo Health?

NYU Clinical Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Clinical Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.